Kailera Therapeutics, Inc. (KLRA)

17.60 -0.15 (-0.85%) USD  |  NASDAQ  |  Aug 26, 12:31
More

Kailera Therapeutics EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for 2 Fiscal Years Ahead Chart
Start Trial

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to 2026. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
July 07, 2026 --
Date Value
May 27, 2026 --
May 12, 2026 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Sana Biotechnology, Inc. Upgrade
Parabilis Medicines, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade